Houfar Sekhavat

This inventor holds 12 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Hexiris Inc., Triple Hair Inc., Pulmonem Inc.. Active years: 2018-2026.

USPTO Granted Patents = 12 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 9)

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 14(Granted Patents)

Company Filing History:

Years Active: 2018-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12708561 - MEDICAL DEVICE FOR DEPLOYMENT WITHIN AN EYE FOR MANAGEMENT OF INTRAOCULAR FLUIDS (2026-08-18),

2. 12594187 - Glaucoma shunts and related methods of use (2026-04-07),

3. 12472099 - Medical device and ocular implant for treatment of ocular disorders (2025-11-18),

4. 12465518 - Device and method for generating a channel in an eye tissue layer for treatment of ocular disorders (2025-11-11),

5. 12396967 - Method of treating a person afflicted with a respiratory condition and pharmaceutical formulation including dapsone (2025-08-26),

6. 12268635 - Glaucoma shunts and related methods of use (2025-04-08),

7. 12053541 - Compositions for reducing hair loss and/or increasing hair regrowth (2024-08-06),

8. 11826323 - Method of treating a person afflicted with COVID-19 and pharmaceutical formulation including dapsone (2023-11-28),

9. 11696883 - Compositions for reducing hair loss and/or increasing hair regrowth (2023-07-11),

10. 11337939 - Dapsone formulations and methods of using same (2022-05-24),

11. 10470992 - Compositions for reducing hair loss and/or increasing hair regrowth (2019-11-12),

12. 10039703 - Composition comprising resveratrol and melatonin for reducing hair loss and/or increasing hair regrowth (2018-08-07),

Title: The Innovative Contributions of Houfar Sekhavat

Introduction

Houfar Sekhavat is a notable inventor based in Dieppe, Canada. He has made significant contributions to the field of medicine, particularly in the treatment of respiratory conditions and glaucoma. With a total of eight patents to his name, Sekhavat's work reflects a commitment to advancing healthcare solutions.

Latest Patents

Among his latest patents is a method for treating patients afflicted with respiratory conditions, including COVID-19. This innovative approach involves administering eighty-five milligrams of dapsone twice daily for twenty-one days. The patent also includes various formulations and delivery devices, such as inhalers, nasal sprays, and oral solutions. Another significant patent involves glaucoma shunts designed to decrease intraocular pressure in the eye. These shunts feature an elongate body with a lumen that facilitates the drainage of aqueous humor, thereby addressing glaucoma effectively.

Career Highlights

Throughout his career, Houfar Sekhavat has worked with several companies, including Triple Hair Inc. and Pulmonem Inc. His experience in these organizations has contributed to his expertise in developing medical innovations.

Collaborations

Sekhavat has collaborated with notable professionals in his field, including Satish Asotra and Nir Shoham-Hazon. These partnerships have likely enhanced his research and development efforts.

Conclusion

Houfar Sekhavat's contributions to medical innovation, particularly in respiratory treatments and glaucoma management, underscore his role as a significant inventor. His patents reflect a dedication to improving patient care and advancing medical technology.